SCHEMBL8933712

SCHEMBL8933712

C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)NC(=O)N(C)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.64
EPHX2 P34913 1/20 0.64
ACACB O00763 8/20 0.39
ACACA Q13085 2/20 0.36
HPGD P15428 2/20 0.34
LIPE Q05469 1/20 0.34
MAPK1 P28482 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
KMT2A Q03164 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8948277 0.81 ALOX5 (0.78) ALOX5EPHX2ACACBACACAHPGD
SCHEMBL15122396 0.81 ALOX5 (0.61) ALOX5EPHX2HPGDMAPK1TSHR
SCHEMBL15122395 0.81 ALOX5 (0.61) ALOX5EPHX2HPGDMAPK1TSHR
SCHEMBL13140100 0.80 ALOX5 (0.83) ALOX5EPHX2HPGD
Atreleuton SCHEMBL504818 0.78 ALOX5 (1.00) ALOX5EPHX2ACACBACACA
Atreleuton SCHEMBL2107799 0.78 ALOX5 (1.00) ALOX5EPHX2ACACBACACA
Atreleuton SCHEMBL2108309 0.78 ALOX5 (1.00) ALOX5EPHX2ACACBACACA
SCHEMBL8304903 0.77 ALOX5 (0.65) ALOX5EPHX2ACACBHPGDKDM4E
SCHEMBL2872801 0.74 ALOX5 (0.73) ALOX5EPHX2
SCHEMBL895799 0.74 ALOX5 (0.52) ALOX5EPHX2ACACBACACAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996032377-A1 LIPOXYGENASE AND CYCLOOXYGENASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1996-10-17 WO disclosed